Curaleaf Holdings, Inc. (CURA.TO)

CAD 1.29

(9.83%)

Total Debt Summary of Curaleaf Holdings, Inc.

  • Curaleaf Holdings, Inc.'s latest annual total debt in 2023 was 1.44 Billion USD , down -6.87% from previous year.
  • Curaleaf Holdings, Inc.'s latest quarterly total debt in 2024 Q1 was 1.46 Billion USD , down -0.8% from previous quarter.
  • Curaleaf Holdings, Inc. reported annual total debt of 1.55 Billion USD in 2022, up 51.95% from previous year.
  • Curaleaf Holdings, Inc. reported annual total debt of 1.02 Billion USD in 2021, up 39.04% from previous year.
  • Curaleaf Holdings, Inc. reported quarterly total debt of 854.82 Million USD for 2024 Q2, down -21.13% from previous quarter.
  • Curaleaf Holdings, Inc. reported quarterly total debt of 1.44 Billion USD for 2023 FY, down -6.87% from previous quarter.

Annual Total Debt Chart of Curaleaf Holdings, Inc. (2023 - 2016)

Historical Annual Total Debt of Curaleaf Holdings, Inc. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 1.44 Billion USD -6.87%
2022 1.55 Billion USD 51.95%
2021 1.02 Billion USD 39.04%
2020 735.99 Million USD 186.5%
2019 256.89 Million CAD 123.11%
2018 115.14 Million CAD 801.48%
2017 12.77 Million CAD 0.0%
2016 - CAD 0.0%

Peer Total Debt Comparison of Curaleaf Holdings, Inc.

Name Total Debt Total Debt Difference
Aurora Cannabis Inc. 104.79 Million CAD -1281.905%
Avicanna Inc. 1.8 Million CAD -80199.101%
Avant Brands Inc. 18.7 Million CAD -7643.084%
Cardiol Therapeutics Inc. 158.53 Thousand CAD -913350.643%
Crescita Therapeutics Inc. 1.25 Million CAD -115379.392%
Knight Therapeutics Inc. 69.09 Million CAD -1995.948%
MediPharm Labs Corp. 2.29 Million CAD -62998.543%
OrganiGram Holdings Inc. 155 Thousand CAD -934165.531%
Canopy Growth Corporation 683.17 Million CAD -111.969%
Willow Biosciences Inc. 2.15 Million CAD -67066.585%
Auxly Cannabis Group Inc. 159.04 Million CAD -810.504%